Clinical & translational oncology

• 

  Año 2020, Vol. 22, Número 5

  • Rosette-forming glioneuronal tumor:: an update

    C.T. Anyanwu, T. M. Robinson, J.H. Huang

    • Resumen

    págs. 623-630

    

  • Emerging roles of aerobic glycolysis in breast cancer

    Z. Wu, J. Wu, Q. Zhao, S. Fu, J. Jin

    • Resumen

    págs. 631-646

    

  • Multidisciplinary management of liver metastases in patients with colorectal cancer:: a consensus of SEOM, AEC, SEOR, SERVEI, and SEMNIM

    E. González Flores, C. Rubio, J. Urbano, M. Valero Camps, Juan José Ciampi Dopazo, Javier Orcajo Rincón, Virginia Morillo Macías, M.A. Gomez Braco, Gonzalo Suárez-Artacho, Ruth Vera García

    • Resumen

    págs. 647-662

    

  • A retrospective study of malignant melanoma from a tertiary care centre in Saudi Arabia from 2004 to 2016

    A. Alshedoukhy, P. Cahusac, J. Kashin, F.H. Alkhawaja, Paul H. Sugarbaker, K. Anwar

    • Resumen

    págs. 663-669

    

  • Role of boost radiotherapy for local control of pure ductal carcinoma in situ after breast-conserving surgery:

    M.J. Cambra, F. Moreno, X. Sanz, L. Anglada, M. Mollá, Victoria Reyes López, Meritxell Arenas Prat, Agustí Pedro, R. Ballester, V. García Reglero, J. Casals, M. Cusidó, C. Jimenez, J. M. Escribà, Miquel Maciá i Garau, J.M. Solé, Àngels Arcusa Lanza, Miguel Ángel Seguí Palmer, S. González, B. Farrús Lucaya, Alberto Biete Solà

    • Resumen

    págs. 670-680

    

  • Whole-exome sequencing of familial esophageal squamous cell carcinoma identified rare pathogenic variants in new predisposition genes

    F.F. Golyan, T.E Druley, M.R. Abbaszadegan

    • Resumen

    págs. 681-693

    

  • The impact of PTEN deletion and ERG rearrangement on recurrence after treatment for prostate cancer: a systematic review and meta-analysis

    J. Zhou, R. Liu, S. Xia, T. Li

    • Resumen

    págs. 694-702

    

  • A new therapeutic approach in very refractory diffuse large B-cell lymphoma

    José Antonio Avilés Izquierdo, María de Jesús Nambo Lucio, N. Neri, S. Cleto, L. Silva

    • Resumen

    págs. 703-707

    

  • Clinical outcomes to pemetrexed-based versus non-pemetrexed-based platinum doublets in patients with KRAS-mutant advanced non-squamous non-small cell lung cancer

    B. Ricciuti, M. Brambilla, A. Cortellini, A. De Giglio, C. Ficorella, A. Sindoni, G. Bellezza, L. Crinò, V. Ludovini, S. Baglivo, G. Metro, R. Chiari

    • Resumen

    págs. 708-716

    

  • Prospective, multicenter study on the economic and clinical impact of gene-expression assays in early-stage breast cancer from a single region:: the PREGECAM registry experience

    Sara Pérez Ramírez, M. del Monte Millán, S. Lopez Tarruella, N. Martínez Jáñez, Iván Márquez Rodas, Francisco Lobo Samper, Yann Izarzugaza, Carlos Rubio Terrés, D. Rubio Rodríguez, José Ángel García Sáenz, Fernando Moreno Antón, P. Zamora Auñon, Mónica Arroyo Yustos, Miguel Ángel Lara Álvarez, Eva Ciruelos, Luis Manso Sánchez, Mª José Echarri, Juan Antonio Guerra Martínez, Carlos Jara Sánchez, Coralia Bueno Muiño, Silvia García Adrián, José Rafael Carrión Galindo, A. Maganto Sancho

    • Resumen

    págs. 717-724

    

  • Prognostic factors for the survival of patients with papillary renal cell carcinoma after surgical management

    W. Ren, X. Gao, X. Zhang, J. Hu, H. Li, X. Zu

    • Resumen

    págs. 725-733

    

  • Optimal duration of first-line chemotherapy for advanced gastric cancer:: data from the AGAMENON registry

    A. Viudez, Alberto Carmona Bayonas, Javier Gallego Plazas, A. Lacalle, Raquel Hernández San Gil, Juana María Cano Cano, I. Macías, Ana Custodio, Eva Martínez de Castro, Alfonso Sánchez Muñoz, L. Iglesia, P. Reguera, Laura Visa, B. Azkárate Ayerdi, M. Sánchez Cánovas, Montserrat Mangas Izquierdo, M. L. Limón Mirón, A. Martínez Torrón, Elena Asensio Martínez, Avi Ramchandani Vaswani, Alfonso Martín Carnicero, José A. Hurtado Martínez, P. Cerdà, M. Garrido, Rodrigo Sánchez Bayona, Raquel Serrano Blanch, P. Jiménez Fonseca

    • Resumen

    págs. 734-750

    

  • Patient safety in radiation oncology in Spain:: a need to change

    José Pardo Masferrer, Elia del Cerro Peñalver, Jorge Contreras Martínez, Carlos Ferrer Albiach

    • Resumen

    págs. 751-758

    

  • Treatment options beyond immunotherapy in patients with wild-type lung adenocarcinoma:: a Delphi consensus

    Dolores Isla Casado, Javier de Castro Carpeño, María Rosario García Campelo, Pilar Lianes Barragán, Enriqueta Felip Font, María Pilar Garrido López, Luis Paz-Ares Rodríguez, José Manuel Trigo Pérez

    • Resumen

    págs. 759-771

    

  • Orphan nuclear receptor COUP-TFII is an oncogenic gene in renal cell carcinoma

    X. Fang, C.X. Liu, X.R. Zeng, X.M. Huang, W.L. Chen, Y. Wang

    • Resumen

    págs. 772-781

    

  • Expression of CD47 antigen in Reed–Sternberg cells as a new potential biomarker for classical Hodgkin lymphoma

    B. López Pereira, Adela Alonso Fernández Velasco, I. Fernández Vega, D. Corte Torres, C. Quirós Herranz, J. A. Villegas, P. Palomo, S. González, Ana Pilar González Rodríguez, A. R. Payer, T. Bernal, M. Moro, R. Alonso Arias, Mª Soledad Álvarez Ruiz, E. Colado

    • Resumen

    págs. 782-785

    

  • Axillary nodal involvement by primary tumor features in early breast cancer: an analysis of 2600 patients

    M.C. De Santis, E. La Rocca, E. Meneghini, G. Bregni, G. Di Lorenzo, G. Galli, M. Di Nicola, S. Folli, M. Gennaro, G. Pruneri, B. Paolini, Maria Grazia Daidone, F. de Braud, G. Apolone, M. Sant, S. Di Cosimo

    • Resumen

    págs. 786-792

    

  • In favor of total neoadjuvant therapy (TNT) for locally advanced rectal carcinoma

    Fernando Arias de la Vega, Gemma Asín Felipe, S. Flamarique, I. Hernández, Javier Gómez Suárez

    págs. 793-794